Evidence map›Paper›PMID 32884954›Full record

ArticleIranian journal of biotechnology2020

Modeling, Mutagenesis and

Nazanin Gholampour-Faroji, Monir-Sadat Shakeri, Jafar Hemmat, Mohammad Rastegar-Moghadam, Aliakbar Haddad-Mashadrizeh

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nazanin Gholampour-FarojiBiotechnology Department, Iranian Research Organization for Science and Technology (IROST). Tehran, Iran.
Monir-Sadat ShakeriBiotechnology Department, Research Institute of Food Science and Technology. Mashhad, Iran.
Jafar HemmatBiotechnology Department, Iranian Research Organization for Science and Technology (IROST). Tehran, Iran.
Mohammad Rastegar-MoghadamStructural Biology and Bioinformatics Research Group, Khayam Bioeconomy Institute (KBI), Mashhad, Iran.
Aliakbar Haddad-MashadrizehIndustrial Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Iranian Research Organization for Science and Technology · IRFerdowsi University of Mashhad · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCharacterizing the structure and function of superoxide dismutase (SOD), as an antioxidant enzyme providing opportunities for its application in food supplements.

objectivesIn this study, the features of the Manganese-SOD of MATERIALS AND

methodsThe protein's physicochemical properties and the prediction of its secondary structure were determined via the ProtParam server and the GOR program respectively. Moreover, the 3D structures of the proteins were constructed via the MODELLER on the basis of the homology method and the threading algorithm MUSTER. On the other hand, the structural stability of the models was assayed under the quasi-physiological conditions by the GROMACS program via the GROMOS96 43a1 force field in Linux system. Finally, using the Molecular Docking Studies, the functionality features of the models were predicted through their affinity with the corresponding substrates.

resultsThe results revealed the physicochemical properties of the SDLL and a 3D model of a chain of the enzyme being similar to the SOD from the

conclusionIn general, the study provides a new model of SDLL with certain thermostable features, and a new mutant with suitable stability and functionality on the basis of the direct mutagenesis being used in different applications.

Indexed as

Antioxidant enzymesdirect Mutagenesisfood supplementsthermostability

Identifiers

PMID32884954
PMCPMC7461707
OpenAlexW3032958925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.